Sensei Biotherapeutics Inc.
13F holders, Q1 2024 (March 31)25holders
3famous investors
$1.05avg. 13F price*
At the end of Q1 2024, 25 institutions reported holding Sensei Biotherapeutics Inc. in their 13F filings. The largest holders were Newtyn Management, LLC ($977K), Vanguard Group Inc. ($603K) and Renaissance Technologies ($222K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Sensei Biotherapeutics Inc.
- CUSIP
- 81728A108
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $21K |
| Exits | 1 | $69K |
Ownership 25 holders
| Newtyn Management, LLC | 0.20% | Reduce -40.8% | 930,230 | $977K |
| Vanguard Group Inc. | 0.00% | Add +0.0% | 573,844 | $603K |
| Renaissance Technologies | 0.00% | Add +47.0% | 211,000 | $222K |
| Geode Capital Management, LLC | 0.00% | No change | 136,318 | $143K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 112,900 | $119K |
| Bank of America Corp. | 0.00% | Reduce -0.0% | 90,763 | $95K |
| BlackRock Inc. | 0.00% | Reduce -3.5% | 33,582 | $35K |
| Millennium Management | 0.00% | Reduce -14.9% | 32,587 | $34K |
| Northern Trust Corp. | 0.00% | No change | 26,049 | $27K |
| State Street Corp. | 0.00% | No change | 25,774 | $27K |
| Citadel Advisors | 0.00% | Reduce -7.5% | 23,864 | $25K |
| Cresset Asset Management, LLC | 0.00% | New | 19,671 | $21K |
| Two Sigma Advisers, LP | 0.00% | No change | 19,000 | $20K |
| Leo Wealth, LLC | 0.00% | No change | 14,845 | $16K |
| Raymond James & Associates | 0.00% | No change | 14,000 | $15K |
| Morgan Stanley | 0.00% | Add +5479.4% | 12,219 | $13K |
| Deuterium Capital Management, LLC | 0.02% | No change | 11,000 | $12K |
| Two Sigma Investments, LP | 0.00% | No change | 10,176 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -20.5% | 6,713 | $7K |
| Banque Cantonale Vaudoise | 0.00% | No change | 3,900 | $4K |
| JPMorgan Chase & Co. | 0.00% | No change | 668 | $701 |
| UBS Group AG | 0.00% | New | 139 | $146 |
| Wells Fargo & Company | 0.00% | Add +1.5% | 133 | $140 |
| Qube Research & Technologies Ltd | 0.00% | No change | 4 | $4 |
| Royal Bank of Canada | 0.00% | Reduce -90.2% | 53 | $0 |
"% of holder's portfolio" is SENSEI BIOTHERAPEUTICS INC's weight in each manager's 13F, not the share of Sensei Biotherapeutics Inc. the manager owns.